Raise watches investors, financings and the conversations in your field around the clock, and tells you who to approach, why now, and who can introduce you.
Private beta. Some features shown are in development.
Feedback written for life science decks: evidence, asset vs. platform, and milestones.
Deck feedback built for life science: evidence, asset vs. platform, and milestones.
Matched to your deck on stage, science, check size and recent deals. Bring your own list too.
Built on each fund’s thesis and recent deals, ready to send from your own email.
A CRM built for the raise: stages, next steps, and one-tap reply logging.
Raise will track podcasts, financings, filings and conferences, and brief you each morning.
It will find paths to investors through your advisors and co-authors, and draft the ask.
It will check each fund’s portfolio for companies that compete with yours.
It will prepare a one-page brief on the partner: recent deals, public remarks, likely questions.
Biotech rounds turn on data readouts, IND timelines and investors who back a modality, not a sector. Generic fundraising tools weren’t built for that. Raise is built by people who have spent years helping life science founders with fundraising, investor strategy, business development and company building, and it’s being shaped with our first beta founders.
We’re building the deepest record of life science investors: the funds, the partners, what they’ve backed and what they’re saying.
Every match shows where its information came from and when it was verified, and says so plainly when it hasn’t been.
Stored privately and encrypted. Our team can’t open it unless you choose to share it, and you can delete it any time.
Firms you add stay in your workspace. We never add them to our shared database.
Raise drafts. It never emails or messages an investor on your behalf.
Pre-seed to Series A: therapeutics, platforms, diagnostics and medtech.